Cargando…

Aspirin use is associated with increased risk for incident heart failure: a patient‐level pooled analysis

AIMS: Recent trials evaluating the effect of aspirin in the primary prevention of cardiovascular disease showed little or no benefit. However, the role of aspirin on the risk of incident heart failure (HF) remains elusive. This study aimed to evaluate the role of aspirin use on HF incidence in prima...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mujaj, Blerim, Zhang, Zhen‐Yu, Yang, Wen‐Yi, Thijs, Lutgarde, Wei, Fang‐Fei, Verhamme, Peter, Delles, Christian, Butler, Javed, Sever, Peter, Latini, Roberto, GF Cleland, John, Zannad, Faiez, Staessen, Jan A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787993/ https://www.ncbi.nlm.nih.gov/pubmed/34808706 http://dx.doi.org/10.1002/ehf2.13688

Ejemplares similares

Renal function in relation to low-level environmental lead exposure
por: Mujaj, Blerim, et al.
Publicado: (2019)

Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK Biobank
por: Rastogi, Tripti, et al.
Publicado: (2022)

Risk factors for predicting heart failure: a subject-level meta-analysis from the HOMAGE database
por: Efremov, Ljupcho, et al.
Publicado: (2015)

Risk for Incident Heart Failure: A Subject‐Level Meta‐Analysis From the Heart “OMics” in AGEing (HOMAGE) Study
por: Jacobs, Lotte, et al.
Publicado: (2017)

ECG Voltage in Relation to Peripheral and Central Ambulatory Blood Pressure
por: Yang, Wen-Yi, et al.
Publicado: (2018)

Conventional and Ambulatory Blood Pressure as Predictors of Diastolic Left Ventricular Function in a Flemish Population
por: Wei, Fang‐Fei, et al.
Publicado: (2018)

Heart rate variability and peripheral nerve conduction velocity in relation to blood lead in newly hired lead workers
por: Yu, Cai-Guo, et al.
Publicado: (2019)

Reproducibility of Retinal Microvascular Traits Decoded by the Singapore I Vessel Assessment Software Across the Human Age Range
por: Huang, Qi-Fang, et al.
Publicado: (2018)

Heart ‘omics’ in AGEing (HOMAGE): design, research objectives and characteristics of the common database
por: Jacobs, Lotte, et al.
Publicado: (2014)

Inactive matrix Gla protein is a novel circulating biomarker predicting retinal arteriolar narrowing in humans
por: Wei, Fang-Fei, et al.
Publicado: (2018)

Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled( )
por: Ferreira, João Pedro, et al.
Publicado: (2022)

Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study
por: Girerd, Nicolas, et al.
Publicado: (2023)

Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure: A Secondary Analysis of EMPEROR-Pooled
por: Ferreira, João Pedro, et al.
Publicado: (2022)

A novel urinary biomarker predicts 1-year mortality after discharge from intensive care
por: Nkuipou-Kenfack, Esther, et al.
Publicado: (2020)

Design of a prospective patient‐level pooled analysis of two parallel trials of empagliflozin in patients with established heart failure
por: Packer, Milton, et al.
Publicado: (2020)

The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trial
por: Cleland, John G F, et al.
Publicado: (2020)

Renal function estimation and Cockcroft–Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart ‘OMics’ in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives
por: Ferreira, João Pedro, et al.
Publicado: (2016)

Neuromodulation in heart failure( )
por: Zannad, Faiez
Publicado: (2022)

Totality of evidence in trials of sodium–glucose co-transporter-2 inhibitors in the patients with heart failure with reduced ejection fraction: implications for clinical practice
por: Butler, Javed, et al.
Publicado: (2020)

Glomerular function in relation to circulating adhesion molecules and inflammation markers in a general population
por: Feng, Ying-Mei, et al.
Publicado: (2018)

Urinary Proteomic Profile of Arterial Stiffness Is Associated With Mortality and Cardiovascular Outcomes
por: Wei, Dongmei, et al.
Publicado: (2022)

Serum insulin levels are associated with vulnerable plaque components in the carotid artery: the Rotterdam Study
por: Mujaj, Blerim, et al.
Publicado: (2020)

Urinary Proteomics in Predicting Heart Transplantation Outcomes (uPROPHET)—Rationale and database description
por: Huang, Qi-Fang, et al.
Publicado: (2017)

Left Ventricular Structure and Function in Relation to Environmental Exposure to Lead and Cadmium
por: Yang, Wen‐Yi, et al.
Publicado: (2017)

Biomarkers to Assess Right Heart Pressures in Recipients of a Heart Transplant: A Proof-of-Concept Study
por: Huang, Qi-Fang, et al.
Publicado: (2018)

Retinal Microvasculature in Relation to Central Hemodynamics in a Flemish Population
por: Wei, Fang-Fei, et al.
Publicado: (2019)

Novel Urinary Peptidomic Classifier Predicts Incident Heart Failure
por: Zhang, Zhen‐Yu, et al.
Publicado: (2017)

Renin-angiotensin-aldosterone system and kidney interactions in heart failure
por: Ferreira, João Pedro, et al.
Publicado: (2019)

Rationale and design of a randomized, double‐blind, event‐driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial
por: Zannad, Faiez, et al.
Publicado: (2015)

Nuclear magnetic resonance‐based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997
por: Delles, Christian, et al.
Publicado: (2017)

Dyskalemia in people at increased risk for heart failure: findings from the heart ‘OMics’ in AGEing (HOMAGE) trial
por: Monzo, Luca, et al.
Publicado: (2022)

Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction
por: Butler, Javed, et al.
Publicado: (2021)

Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation issues and future developments
por: Zannad, Faiez, et al.
Publicado: (2019)

Diastolic Left Ventricular Function in Relation to Urinary and Serum Collagen Biomarkers in a General Population
por: Zhang, Zhen-Yu, et al.
Publicado: (2016)

Identification of sex‐specific biomarkers predicting new‐onset heart failure
por: Raafs, Anne, et al.
Publicado: (2021)

Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR‐Reduced
por: Ferreira, João Pedro, et al.
Publicado: (2022)

Diastolic left ventricular function in relation to the retinal microvascular fractal dimension in a Flemish population
por: Wei, Fang-Fei, et al.
Publicado: (2021)

Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure
por: Packer, Milton, et al.
Publicado: (2023)

Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER‐like endpoint definitions
por: Anker, Stefan D., et al.
Publicado: (2022)

Daily home monitoring of potassium, creatinine, and estimated plasma volume in heart failure post‐discharge
por: Rossignol, Patrick, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u1ntemja4j14ihedmj0ui8jj3c